ESR1 and cancer: It should be mentioned that the activity elicited by ER antagonists, though ERα and GPER as stated above, could represent a therapeutic concern with regard to the pharmacological manipulation of cancer cells, through inhibiting all types of estrogen receptors, however, in PCa, it has not yet been fully elucidated